Cite
HARVARD Citation
Cornell, R. et al. (2022). A phase 1 clinical trial of oral eltanexor in patients with relapsed or refractory multiple myeloma. American journal of hematology. 97 (2), pp. E54-E58. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Cornell, R. et al. (2022). A phase 1 clinical trial of oral eltanexor in patients with relapsed or refractory multiple myeloma. American journal of hematology. 97 (2), pp. E54-E58. [Online].